LEADER 03906nam 2200745Ia 450 001 9910972922403321 005 20251017110201.0 010 $a9786611767266 010 $a9780309177856 010 $a0309177855 010 $a9781281767264 010 $a1281767263 010 $a9780309119955 010 $a0309119952 035 $a(CKB)1000000000539244 035 $a(OCoLC)263436553 035 $a(CaPaEBR)ebrary10246293 035 $a(SSID)ssj0000149678 035 $a(PQKBManifestationID)11144985 035 $a(PQKBTitleCode)TC0000149678 035 $a(PQKBWorkID)10238625 035 $a(PQKB)11105434 035 $a(MiAaPQ)EBC3564148 035 $a(Au-PeEL)EBL3564148 035 $a(CaPaEBR)ebr10246293 035 $a(CaONFJC)MIL176726 035 $a(Perlego)4736595 035 $a(DNLM)1485254 035 $a(BIP)23194547 035 $a(EXLCZ)991000000000539244 100 $a20080521d2008 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEstimating mortality risk reduction and economic benefits from controlling ozone air pollution /$fCommittee on Estimating Mortality Risk Reduction Benefits from Decreasing Tropospheric Ozone Exposure, Board on Environmental Studies and Toxicology, Division on Earth and Life Studes, National Research Council of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$dc2008 215 $a1 online resource (226 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309119948 311 08$a0309119944 320 $aIncludes bibliographical references (p. 182-203). 327 $aIntroduction -- Overview of ambient-ozone standards development and benefits assessment -- Ambient ozone and related pollutants -- Contributions of relevant health studies to the estimation of reductions in premature mortality -- Economic valuation of reduction in mortality risk associated with ambient ozone -- Overall conclusions and recommendations. 330 $aIn light of recent evidence on the relationship of ozone to mortality and questions about its implications for benefit analysis, the Environmental Protection Agency asked the National Research Council to establish a committee of experts to evaluate independently the contributions of recent epidemiologic studies to understanding the size of the ozone-mortality effect in the context of benefit analysis. The committee was also asked to assess methods for estimating how much a reduction in short-term exposure to ozone would reduce premature deaths, to assess methods for estimating associated increases in life expectancy, and to assess methods for estimating the monetary value of the reduced risk of premature death and increased life expectancy in the context of health-benefits analysis. Estimating Mortality Risk Reduction and Economic Benefits from Controlling Ozone Air Pollution details the committee's findings and posits several recommendations to address these issues. 606 $aAir$xPollution$xStandards$zUnited States 606 $aAtmospheric ozone$xStandards$zUnited States 606 $aContingent valuation 606 $aEnvironmental risk assessment 606 $aHealth risk assessment 615 0$aAir$xPollution$xStandards 615 0$aAtmospheric ozone$xStandards 615 0$aContingent valuation. 615 0$aEnvironmental risk assessment. 615 0$aHealth risk assessment. 676 $a363.7384 712 02$aNational Research Council (U.S.).$bBoard on Environmental Studies and Toxicology. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910972922403321 996 $aEstimating mortality risk reduction and economic benefits from controlling ozone air pollution$94358917 997 $aUNINA